{"id":5452,"date":"2014-12-02T09:53:00","date_gmt":"2014-12-02T09:53:00","guid":{"rendered":"https:\/\/aspree.org\/aus\/?p=5452"},"modified":"2021-08-23T00:36:52","modified_gmt":"2021-08-23T00:36:52","slug":"aspree-investigator-interview-on-radio-national-health-report","status":"publish","type":"post","link":"https:\/\/aspree.org\/aus\/aspree-investigator-interview-on-radio-national-health-report\/","title":{"rendered":"ASPREE Investigator interview on Radio National Health Report"},"content":{"rendered":"\r\n<h2 class=\"wp-block-heading\">A recap on aspirin and primary prevention aspirin trials<\/h2>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<p>Professor Mark Nelson, <a href=\"\/aus\/about-us\/\">Chief Investigator<\/a> to the ASPREE trial in Tasmania, talks to Norman Swan about aspirin and primary prevention<\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<figure class=\"wp-block-image size-large is-resized\"><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-5457\" src=\"https:\/\/aspree.org\/wp-content\/uploads\/sites\/2\/2021\/03\/Prof-Mark-Nelson.ed_.jpg\" alt=\"Mature white man with grey hair wearing glasses and a pale shirt and tie sits in front of a grey\/blue background\" width=\"430\" height=\"429\" \/>\r\n<figcaption><em>Above: Practicing GP, Prof. Mark Nelson, a Chief Investigator to the ASPREE trial in Tasmania, recently spoke with Norman Swan about aspirin studies on the ABC Health Report.<\/em><\/figcaption>\r\n<\/figure>\r\n\r\n\r\n\r\n<p>Prof Nelson discusses findings from the JPPP (Japanese Primary Prevention Project) and the aims of the ASPREE trial.<\/p>\r\n\r\n\r\n\r\n<p>To listen to the interview\u00a0<a href=\"http:\/\/mpegmedia.abc.net.au\/rn\/podcast\/2014\/12\/hrt_20141201_1730.mp3\" target=\"_blank\" rel=\"noreferrer noopener\">click here<\/a>. Read the\u00a0<a href=\"http:\/\/www.abc.net.au\/radionational\/programs\/healthreport\/the-effectiveness-of-aspirin-in-the-prevention-of-heart-disease\/5925030\" target=\"_blank\" rel=\"noreferrer noopener\">transcript here<\/a>.<\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Practicing GP and Chief Investigator to the ASPREE trial in Tasmania, Prof. Mark Nelson,  recently spoke with Norman Swan about aspirin studies on the ABC Health Report.<\/p>\n","protected":false},"author":2,"featured_media":5453,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"1200","footnotes":""},"categories":[17,18,16],"tags":[28,73],"_links":{"self":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/5452"}],"collection":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/comments?post=5452"}],"version-history":[{"count":12,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/5452\/revisions"}],"predecessor-version":[{"id":8481,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/5452\/revisions\/8481"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/media\/5453"}],"wp:attachment":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/media?parent=5452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/categories?post=5452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/tags?post=5452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}